Rosacea (Dermatology) Pipeline Landscape H1 2017 Market report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Companies of Rosacea Pipeline Review, H1 2017 main companies are Amorepacific Corp, BioPharmX Inc, Cutanea Life Sciences Inc, ELORAC Inc, Foamix Pharmaceuticals Ltd, Hovione FarmaCiencia SA, Promius Pharma LLC, Sol-Gel Technologies Ltd.
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=992894
Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Symptoms include frequent redness of the face, or flushing, small, red lines under the skin, a swollen nose and thick skin, usually on the forehead, chin, and cheeks. The predisposing factors include age and family history of rosacea. Treatment includes antibiotics and acne drugs.
Rosacea – Drug Profiles – AC-701, ACUD-1, benzoyl peroxide, carbamide peroxide, DFD-29, DMT-200, DMT-210, DMT-220, EP-0003, FMX-103 more..
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=992894
- The pipeline guide provides a snapshot of the global therapeutic landscape of Rosacea (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Rosacea (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rosacea (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rosacea (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rosacea (Dermatology)
List of Tables
Number of Products under Development for Rosacea, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Rosacea – Pipeline by Amorepacific Corp, H1 2017
Rosacea – Pipeline by BioPharmX Inc, H1 2017
Rosacea – Pipeline by Cutanea Life Sciences Inc, H1 2017
Rosacea – Pipeline by ELORAC Inc, H1 2017
Rosacea – Pipeline by Foamix Pharmaceuticals Ltd, H1 2017
Rosacea – Pipeline by Hovione FarmaCiencia SA, H1 2017
Rosacea – Pipeline by Promius Pharma LLC, H1 2017
Rosacea – Pipeline by Sol-Gel Technologies Ltd, H1 2017
Rosacea – Dormant Projects, H1 2017
Rosacea – Discontinued Products, H1 2017
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.